- Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit: Click here to read the announcement
- SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer: Click here to read the press release
- SafeHeal Announces Successful Launch of IDE Study for Colovac1 Endoluminal Bypass Sheath: Click here to read the press release
Videos
Press Releases
17 March, 2023
Chief Executive Officer Chris Richardson to Speak at LSI Emerging Medtech Summit
Chris Richardson, CEO of SafeHeal, will be presenting an overview of the...
Read More
11 July, 2022
SafeHeal appoints medical device industry veteran Chris Richardson as Chief Executive Officer
Breakthrough device promises significantly improved patient recovery after colorectal surgery.
Read More
1 April, 2022
SafeHeal Announces Successful Launch of IDE Study for Colovac Endoluminal Bypass Sheath
Apr 01, 2022 - Breakthrough device promises significantly improved patient recovery after...
Read More3 April, 2019
SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath
Apr 03, 2019 - SafeHeal, a leading innovator in the field of...
Read More11 January, 2019
SafeHeal Completes First-in-Human Clinical Study of Endoluminal Bypass Sheath
Jan 11, 2019 - SafeHeal, an innovator in the field of digestive...
Read More29 January, 2018
SAFEHEAL starts first-in-human and CE-mark clinical study of endoluminal bypass sheath with the potential of replacing ostomy
Jan 29, 2018 -The study will evaluate safety and efficacy of the...
Read More16 October, 2017
SafeHeal Appoints Dr. Karl Blohm as CEO to Prepare for Launch and Commercialization
Apr 03, 2019 - SafeHeal, a leading innovator in the field of...
Read More1 Colovac is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.
V5_06082023